|
Real-time Estimate
Cboe BZX
23:03:57 22/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 447.95 USD | +2.19% |
|
+3.00% | +36.58% |
| 10-21 | Barclays Adjusts Price Target on Amgen to $400 From $380 | MT |
| 10-21 | Positive Results for an AstraZeneca and Amgen Product |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | +1.99% | +3.00% | +36.58% | +51.04% | +113.65% | 237B |  |  | |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
